Key result
Prior administration of p-coumaric acid and naringenin ameliorated doxorubicin-induced biochemical alterations, including MDA, SOD, CAT, and GSH levels, in male rats.
Why the study?
Does the combination of p-coumaric acid and naringenin prevent doxorubicin-induced cardiotoxicity in male Swiss albino rats?
Population
Male Swiss albino rats (9 groups)
Comparison
Combination of p-coumaric acid and naringenin… vs Vehicle control, disease control, p-coumaric…
Design
Preclinical
Follow-up
30 days
Authors
Loading...
Should not change doxorubicin regimens; hypothesis-generating for flavonoid cardioprotection in anthracycline models.
Does the combination of p-coumaric acid and naringenin prevent doxorubicin-induced cardiotoxicity in male Swiss albino rats?
The combination of p-coumaric acid and naringenin protects against doxorubicin-induced cardiotoxicity in a rat model by ameliorating oxidative stress markers.
Shiromwar et al. (2011) studied Doxorubicin-induced cardiotoxicity. Combination of p-coumaric acid (PC) and naringenin (NR) vs. Doxorubicin alone (disease control) and vehicle control was evaluated on Biochemical markers of cardiac toxicity (MDA, SOD, CAT, and GSH levels). Prior administration of p-coumaric acid and naringenin ameliorated doxorubicin-induced biochemical alterations, including MDA, SOD, CAT, and GSH levels, in male rats.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: